Sign inJoin waitlistJoin the waitlist

LE

Leisha Emens

Physician · JHU - 4692 MILLENNIUM DRIVE - PHYSICIAN

Credentials: · · · ·

History

JHU - 4692 MILLENNIUM DRIVE - PHYSICIAN
Present

UPMC Medical Education
1998–2000
Internal Medicine
1995–1998
Baylor College of Medicine
1991–1995

Research

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
New England Journal of Medicine · 2018 · 3,425 citations
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results…
The Lancet Oncology · 2020 · 978 citations
The interplay of immunotherapy and chemotherapy: harnessing potential synergies
Review · Cancer Immunology Research · 2015 · First of 2 authors · Corresponding · 675 citations

Elizabeth Jaffee
27 papers
Ashley Cimino-Mathews
19 papers · 2 as a resident
Nancy Davidson
15 papers
JF
John Fetting
12 papers
Vered Stearns
12 papers
AW
Antonio Wolff
11 papers
SC
Stephen Chui
9 papers
Deborah Armstrong
8 papers
Pedram Argani
8 papers
Hope Rugo
7 papers
Sylvia Adams
7 papers
CS
Cesar Santa-Maria
6 papers

Grants

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $220.9K · University of Pittsburgh at Pittsburgh
1997–2025
Summer Translational Oncology Program (STOP)
National Cancer Institute · R25
PI · $195.5K · Johns Hopkins University
2013–2018
Chemoimmunotherapy for Breast Cancer Treatment
National Cancer Institute · K23
Contact PI · $554K · Johns Hopkins University
2003–2008

Clinical trials

Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2009–2016
Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2008–2013
Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2006–2010
Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer
Principal investigator · Completed · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2004